Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.5 EUR
−5.16 M EUR
97.00 M EUR
7.09 M
About COSMO PHARM N
Sector
CEO
Giovanni di Napoli
Headquarters
Dublin
Website
Founded
2016
ISIN
NL0011832936
FIGI
BBG01Q6C1PQ3
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of COPN is 68.0 EUR — it has decreased by −0.72% in the past 24 hours. Watch COSMO PHARMACEUTICALS NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange COSMO PHARMACEUTICALS NV stocks are traded under the ticker COPN.
COPN stock has fallen by −3.52% compared to the previous week, the month change is a −14.38% fall, over the last year COSMO PHARMACEUTICALS NV has showed a −16.56% decrease.
We've gathered analysts' opinions on COSMO PHARMACEUTICALS NV future price: according to them, COPN price has a max estimate of 141.42 EUR and a min estimate of 84.31 EUR. Watch COPN chart and read a more detailed COSMO PHARMACEUTICALS NV stock forecast: see what analysts think of COSMO PHARMACEUTICALS NV and suggest that you do with its stocks.
COPN reached its all-time high on Sep 27, 2024 with the price of 81.5 EUR, and its all-time low was 68.5 EUR and was reached on Nov 6, 2024. View more price dynamics on COPN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COPN stock is 1.47% volatile and has beta coefficient of 0.76. Track COSMO PHARMACEUTICALS NV stock price on the chart and check out the list of the most volatile stocks — is COSMO PHARMACEUTICALS NV there?
Today COSMO PHARMACEUTICALS NV has the market capitalization of 1.10 B, it has decreased by −3.32% over the last week.
Yes, you can track COSMO PHARMACEUTICALS NV financials in yearly and quarterly reports right on TradingView.
COSMO PHARMACEUTICALS NV is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
COPN net income for the last half-year is 75.88 M EUR, while the previous report showed −6.61 M EUR of net income which accounts for 1.25 K% change. Track more COSMO PHARMACEUTICALS NV financial stats to get the full picture.
Yes, COPN dividends are paid annually. The last dividend per share was 2.00 EUR. As of today, Dividend Yield (TTM)% is 3.02%. Tracking COSMO PHARMACEUTICALS NV dividends might help you take more informed decisions.
As of Nov 13, 2024, the company has 325.00 employees. See our rating of the largest employees — is COSMO PHARMACEUTICALS NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COSMO PHARMACEUTICALS NV EBITDA is 98.41 M EUR, and current EBITDA margin is 20.43%. See more stats in COSMO PHARMACEUTICALS NV financial statements.
Like other stocks, COPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMO PHARMACEUTICALS NV stock right from TradingView charts — choose your broker and connect to your account.